Home › Funds › T3 Companies, LLC › TOI
T3 Companies, LLC position in TOI
STARLING ONCOLOGY INC COM
T3 Companies, LLC reported holding 64,500 shares of TOI (STARLING ONCOLOGY INC COM) in its Q3 2026 13F filing — a position valued at US$408K, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. T3 Companies, LLC has disclosed TOI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR
How T3 Companies, LLC's TOI position evolved
T3 Companies, LLC first disclosed a stake in TOI in Q4 2025 at 201,100 shares (US$716K). Across 4 filings, T3 Companies, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 64,500 shares valued at US$408K — a reduction of -15,500 shares quarter over quarter.. Notable position changes include a 44% trim in Q1 2026, a 29% trim in Q2 2026.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 201.10K | $715.92K | New |
| Q1 2026 | 111.90K | $343.53K | Reduce |
| Q2 2026 | 80.00K | $434.40K | Reduce |
| Q3 2026 | 64.50K | $407.64K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TOI and 13F data
TOI (STARLING ONCOLOGY INC COM) is a company whose sector is not yet classified in our data. 64 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$9.3M), BRC Group Holdings, Inc. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TOI
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2.46M sh · $13.38M · Q2 2026
- WEXFORD CAPITAL LP 1.71M sh · $9.29M · Q2 2026
- BRC Group Holdings, Inc. 742.59K sh · $4.03M · Q2 2026
- FourWorld Capital Management LLC 499.20K sh · $2.71M · Q2 2026
- Manatuck Hill Partners, LLC 450.00K sh · $2.44M · Q2 2026
- Dauntless Investment Group, LLC 163.57K sh · $888.18K · Q2 2026
- Panoramic Capital, LLC 100.00K sh · $543.00K · Q2 2026
More on T3 Companies, LLC
FAQ
How long has T3 Companies, LLC held TOI?
T3 Companies, LLC has disclosed TOI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is T3 Companies, LLC's current position in TOI?
As of Q3 2026, T3 Companies, LLC holds 64.50K shares of TOI (STARLING ONCOLOGY INC COM), valued at $407.64K, representing 0.77% of its reported portfolio and ranking #35.
Has T3 Companies, LLC been buying or selling TOI?
In the latest 13F filing (Q3 2026), T3 Companies, LLC reduced its position in TOI.
Which other funds hold TOI?
Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.